What is the dosage of adagrasib? How to adjust

The recommended dose of Adagrasib is usually 600 mg taken orally twice daily. This dose is appropriate for most adult patients, particularly those with KRAS G12C-mutated non-small cell lung cancer (NSCLC) or metastatic colorectal cancer (mCRC). Adagrasiib should be taken according to the dosage prescribed by your doctor. Do not adjust the dosage or stop taking the medicine on your own.

During the actual treatment process, the dosage of adagrasiib may need to be adjusted based on the patient's tolerance and efficacy. If the patient experiences adverse reactions, especially serious side effects (such as liver function damage, gastrointestinal discomfort, etc.), the doctor may reduce the dose or temporarily discontinue the drug depending on the specific situation until the symptoms are relieved. For patients who are underweight or have liver or kidney damage, doctors may recommend adjusting the dose to reduce the occurrence of side effects.

In addition, patients' liver and kidney function should be monitored regularly during adagrasiib treatment. In particular, elevated liver enzymes require attention, and doctors may make necessary interventions based on the patient's specific condition. For those patients who experience serious adverse reactions, doctors may recommend discontinuing adagrasiib and pursuing other treatment options.

In general, the dosage of adagrasiib is usually600 mg twice daily, but during treatment, the patient's physical condition, drug tolerance, and side effects may require doctors to make adjustments based on specific circumstances. During the medication process, patients should follow the doctor's instructions and undergo necessary examinations regularly to ensure the safety and efficacy of the medication. If any side effects or uncomfortable symptoms occur, patients should report to the doctor in time to ensure the smooth progress of treatment.

References：https://www.krazati.com/